Benitec Biopharma Inc. Annual Nonoperating Income (Expense) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Benitec Biopharma Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2019 to 2023.
  • Benitec Biopharma Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$138K, a 146% decline year-over-year.
  • Benitec Biopharma Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$200K, a 71.4% increase year-over-year.
  • Benitec Biopharma Inc. annual Nonoperating Income (Expense) for 2023 was -$481K, a 35.9% decline from 2022.
  • Benitec Biopharma Inc. annual Nonoperating Income (Expense) for 2022 was -$354K, a 23.8% decline from 2021.
  • Benitec Biopharma Inc. annual Nonoperating Income (Expense) for 2021 was -$286K, a 4186% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$481K -$127K -35.9% Jul 1, 2022 Jun 30, 2023 10-K 2023-09-21
2022 -$354K -$68K -23.8% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-21
2021 -$286K -$293K -4186% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-02
2020 $7K -$19K -73.1% Jul 1, 2019 Jun 30, 2020 10-K 2021-09-20
2019 $26K Jul 1, 2018 Jun 30, 2019 10-K 2020-09-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.